Skip to search formSkip to main contentSkip to account menu

Aranesp

Known as: Aranest 
National Institutes of Health

Related topics

Related topics

3 relations
0.4 ML darbepoetin alfa 0.025 MG/ML Prefilled Syringe [Aranesp]0.4 ML darbepoetin alfa 0.5 MG/ML Prefilled Syringe [Aranesp]

Broader (1)

darbepoetin alfa

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
1 C-Reactive Protein and Risk of End-Stage Renal Disease – Results from TREAT ( Trial to Reduce cardiovascular Events with Aranesp Therapy )
Word Count: 269 Body Word Count: 3,205 Date: July 5th 2016 Running Title: CRP and risk of ESRD Correspondence to: Finnian Mc… 
2014
2014
Erythropoiesis-stimulating agent use among non-dialysis-dependent CKD patients before and after the trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) using a large US health plan…
BACKGROUND In a landmark study, TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) examined the use of… 
2013
2013
Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm.
BACKGROUND Sparse data are available about the natural history of hemoglobin (Hb) level trends in contemporary patients with… 
2010
2010
Anemia: What can we learn from a secondary analysis of CHOIR?
The findings of a secondary analysis of the CHOIR trial—which evaluated the beneficial and harmful effects of anemia correction… 
Review
2009
Review
2009
Observational Aranesp® Survey to Investigate the Q3W Schedule (OASIS): a prospective observational study of treatment of chemotherapy-induced anaemia with every 3 weeks darbepoetin alfa
IntroductionThis prospective observational study examined the adherence to published European guidelines on erythropoiesis… 
Review
2008
Review
2008
Charge capture: does your process ensure accuracy of the revenue cycle?
As oncology practices work to succeed in today's environment of decreasing reimbursement and the increasing cost of new drugs… 
Review
2008
Review
2008
Are the synergistic effects of high-volume haemofiltration and enhanced adsorption the missing key in sepsis modulation?
38. Canaud B, Mingardi G, Braun J et al. STRIATA Study Investigators. Intravenous C.E.R.A. maintains stable haemoglobin levels in… 
2007
2007
Lack of data mires Aranesp in controversy
Citing patients’ needs and unhappy with the US Food and Drug Administration placing a black box warning on Aranesp, as well as a… 
2007
2007
DRUG NEWS Boxed Warning for Anti-anemia Drugs : Aranesp , Epogen , and Procrit
  • 2007
  • Corpus ID: 1589726
NEW DRUGS Lapatinib (Tykerb) For Advanced Breast Cancer The Food and Drug Administration (FDA) has approved lapatinib (Tykerb… 
2002
2002
Clinical trial simulation of a 200-microg fixed dose of darbepoetin alfa in chemotherapy-induced anemia.
Our objective was to assess, using clinical trial simulation, the feasibility of a fixed 200-microg dose of darbepoetin alfa… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)